 |
PDBsum entry 1cyb
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immunosuppressant
|
PDB id
|
|
|
|
1cyb
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
30:6574-6583
(1991)
|
|
PubMed id:
|
|
|
|
|
| |
|
NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding.
|
|
S.W.Fesik,
R.T.Gampe,
H.L.Eaton,
G.Gemmecker,
E.T.Olejniczak,
P.Neri,
T.F.Holzman,
D.A.Egan,
R.Edalji,
R.Simmer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cyclosporin A (CsA), a potent immunosuppressant, is known to bind with high
specificity to cyclophilin (CyP), a 17.7 kDa protein with peptidyl-prolyl
isomerase activity. In order to investigate the three-dimensional structure of
the CsA/CyP complex, we have applied a variety of multidimensional NMR methods
in the study of uniformly 13C-labeled CsA bound to cyclophilin. The 1H and 13C
NMR signals of cyclosporin A in the bound state have been assigned, and from a
quantitative interpretation of the 3D NOE data, the bound conformation of CsA
has been determined. Three-dimensional structures of CsA calculated from the NOE
data by using a distance geometry/simulated appealing protocol were found to be
very different from previously determined crystalline and solution conformations
of uncomplexed CsA. In addition, from CsA/CyP NOEs, the portions of CsA that
interact with cyclophilin were identified. For the most part, those CsA residues
with NOEs to cyclophilin were the same residues important for cyclophilin
binding and immunosuppressive activity as determined from structure/activity
relationships. The structural information derived in this study together with
the known structure/activity relationships for CsA analogues may prove useful in
the design of improved immunosuppressants. Moreover, the approach that is
described for obtaining the structural information is widely applicable to the
study of small molecule/large molecule interactions.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Ghezzi,
S.Casagrande,
T.Massignan,
M.Basso,
E.Bellacchio,
L.Mollica,
E.Biasini,
R.Tonelli,
I.Eberini,
E.Gianazza,
W.W.Dai,
M.Fratelli,
M.Salmona,
B.Sherry,
and
V.Bonetto
(2006).
Redox regulation of cyclophilin A by glutathionylation.
|
| |
Proteomics,
6,
817-825.
|
 |
|
|
|
|
 |
L.M.Henriksson,
P.Johansson,
T.Unge,
and
S.L.Mowbray
(2004).
X-ray structure of peptidyl-prolyl cis-trans isomerase A from Mycobacterium tuberculosis.
|
| |
Eur J Biochem,
271,
4107-4113.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Volpon,
H.Lamthanh,
J.Barbier,
N.Gilles,
J.Molgó,
A.Ménez,
and
J.M.Lancelin
(2004).
NMR solution structures of delta-conotoxin EVIA from Conus ermineus that selectively acts on vertebrate neuronal Na+ channels.
|
| |
J Biol Chem,
279,
21356-21366.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Altschuh
(2002).
Cyclosporin A as a model antigen: immunochemical and structural studies.
|
| |
J Mol Recognit,
15,
277-285.
|
 |
|
|
|
|
 |
P.Sedmera,
A.Jegorov,
M.Buchta,
and
L.Cvak
(2001).
11-Demethylcyclosporins exhibit a single conformation in methanol and dimethylsulfoxide.
|
| |
J Pept Res,
58,
229-236.
|
 |
|
|
|
|
 |
A.Zvi,
D.J.Feigelson,
Y.Hayek,
and
J.Anglister
(1997).
Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
|
| |
Biochemistry,
36,
8619-8627.
|
 |
|
|
|
|
 |
D.Braaten,
H.Ansari,
and
J.Luban
(1997).
The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein.
|
| |
J Virol,
71,
2107-2113.
|
 |
|
|
|
|
 |
G.Melacini,
Q.Zhu,
and
M.Goodman
(1997).
Multiconformational NMR analysis of sandostatin (octreotide): equilibrium between beta-sheet and partially helical structures.
|
| |
Biochemistry,
36,
1233-1241.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Ottleben,
M.Haasemann,
R.Ramachandran,
M.Görlach,
W.Müller-Esterl,
and
L.R.Brown
(1997).
An NMR study of the interaction of 15N-labelled bradykinin with an antibody mimic of the bradykinin B2 receptor.
|
| |
Eur J Biochem,
244,
471-478.
|
 |
|
|
|
|
 |
M.Marraud,
and
A.Aubry
(1996).
Crystal structures of peptides and modified peptides.
|
| |
Biopolymers,
40,
45-83.
|
 |
|
|
|
|
 |
Y.Fraenkel,
D.E.Shalev,
J.M.Gershoni,
and
G.Navon
(1996).
Nuclear magnetic resonance (NMR) analysis of ligand receptor interactions: the cholinergic system--a model.
|
| |
Crit Rev Biochem Mol Biol,
31,
273-301.
|
 |
|
|
|
|
 |
E.K.Franke,
B.X.Chen,
I.Tatsis,
A.Diamanduros,
B.F.Erlanger,
and
J.Luban
(1995).
Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody.
|
| |
J Virol,
69,
5821-5823.
|
 |
|
|
|
|
 |
J.R.Bagu,
F.D.Sönnichsen,
D.Williams,
R.J.Andersen,
B.D.Sykes,
and
C.F.Holmes
(1995).
Comparison of the solution structures of microcystin-LR and motuporin.
|
| |
Nat Struct Biol,
2,
114-116.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Spitzfaden,
W.Braun,
G.Wider,
H.Widmer,
and
K.Wüthrich
(1994).
Determination of the NMR solution structure of the cyclophilin A-cyclosporin A complex.
|
| |
J Biomol NMR,
4,
463-482.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Altschuh,
W.Braun,
J.Kallen,
V.Mikol,
C.Spitzfaden,
J.C.Thierry,
O.Vix,
M.D.Walkinshaw,
and
K.Wüthrich
(1994).
Conformational polymorphism of cyclosporin A.
|
| |
Structure,
2,
963-972.
|
 |
|
|
|
|
 |
H.Ke,
D.Mayrose,
P.J.Belshaw,
D.G.Alberg,
S.L.Schreiber,
Z.Y.Chang,
F.A.Etzkorn,
S.Ho,
and
C.T.Walsh
(1994).
Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A.
|
| |
Structure,
2,
33-44.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Kubinyi
(1994).
[The key and the lock. I. The basis of drug action]
|
| |
Pharm Unserer Zeit,
23,
158-168.
|
 |
|
|
|
|
 |
H.Liang,
X.Mao,
E.T.Olejniczak,
D.G.Nettesheim,
L.Yu,
R.P.Meadows,
C.B.Thompson,
and
S.W.Fesik
(1994).
Solution structure of the ets domain of Fli-1 when bound to DNA.
|
| |
Nat Struct Biol,
1,
871-875.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.W.MacArthur,
P.C.Driscoll,
and
J.M.Thornton
(1994).
NMR and crystallography--complementary approaches to structure determination.
|
| |
Trends Biotechnol,
12,
149-153.
|
 |
|
|
|
|
 |
A.Thomas,
B.Roux,
and
J.C.Smith
(1993).
Computer simulations of the flexibility of a series of synthetic cyclic peptide analogues.
|
| |
Biopolymers,
33,
1249-1270.
|
 |
|
|
|
|
 |
G.Zenke,
G.Baumann,
R.Wenger,
P.Hiestand,
V.Quesniaux,
E.Andersen,
and
M.H.Schreier
(1993).
Molecular mechanisms of immunosuppression by cyclosporins.
|
| |
Ann N Y Acad Sci,
685,
330-335.
|
 |
|
|
|
|
 |
H.Ke,
Y.Zhao,
F.Luo,
I.Weissman,
and
J.Friedman
(1993).
Crystal structure of murine cyclophilin C complexed with immunosuppressive drug cyclosporin A.
|
| |
Proc Natl Acad Sci U S A,
90,
11850-11854.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.D.Kopple,
J.W.Bean,
K.K.Bhandary,
J.Briand,
C.A.D'Ambrosio,
and
C.E.Peishoff
(1993).
Conformational mobility in cyclic oligopeptides.
|
| |
Biopolymers,
33,
1093-1099.
|
 |
|
|
|
|
 |
O.Vix,
B.Rees,
J.C.Thierry,
and
D.Altschuh
(1993).
Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody.
|
| |
Proteins,
15,
339-348.
|
 |
|
|
|
|
 |
R.A.Wiley,
and
D.H.Rich
(1993).
Peptidomimetics derived from natural products.
|
| |
Med Res Rev,
13,
327-384.
|
 |
|
|
|
|
 |
S.W.Fesik
(1993).
NMR structure-based drug design.
|
| |
J Biomol NMR,
3,
261-269.
|
 |
|
|
|
|
 |
C.A.Lepre,
J.A.Thomson,
and
J.M.Moore
(1992).
Solution structure of FK506 bound to FKBP-12.
|
| |
FEBS Lett,
302,
89-96.
|
 |
|
|
|
|
 |
D.Binge
(1992).
Molecular matchmakers.
|
| |
Curr Biol,
2,
545-547.
|
 |
|
|
|
|
 |
J.J.Siekierka,
and
N.H.Sigal
(1992).
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
|
| |
Curr Opin Immunol,
4,
548-552.
|
 |
|
|
|
|
 |
J.Wu,
and
A.S.Serianni
(1992).
Isotope-edited 1D and 2D n.m.r. spectroscopy of 13C-substituted carbohydrates.
|
| |
Carbohydr Res,
226,
209-218.
|
 |
|
|
|
|
 |
L.D.Zydowsky,
F.A.Etzkorn,
H.Y.Chang,
S.B.Ferguson,
L.A.Stolz,
S.I.Ho,
and
C.T.Walsh
(1992).
Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition.
|
| |
Protein Sci,
1,
1092-1099.
|
 |
|
|
|
|
 |
M.Gurrath,
G.Müller,
H.Kessler,
M.Aumailley,
and
R.Timpl
(1992).
Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides.
|
| |
Eur J Biochem,
210,
911-921.
|
 |
|
|
|
|
 |
W.J.Chazin
(1992).
NMR structures and methodology.
|
| |
Curr Opin Biotechnol,
3,
326-332.
|
 |
|
|
|
|
 |
H.M.Ke,
L.D.Zydowsky,
J.Liu,
and
C.T.Walsh
(1991).
Crystal structure of recombinant human T-cell cyclophilin A at 2.5 A resolution.
|
| |
Proc Natl Acad Sci U S A,
88,
9483-9487.
|
 |
|
|
|
|
 |
P.Neri,
R.Meadows,
G.Gemmecker,
E.Olejniczak,
D.Nettesheim,
T.Logan,
R.Simmer,
R.Helfrich,
T.Holzman,
and
J.Severin
(1991).
1H, 13C and 15N backbone assignments of cyclophilin when bound to cyclosporin A (CsA) and preliminary structural characterization of the CsA binding site.
|
| |
FEBS Lett,
294,
81-88.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |